December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about NASDAQ:MIRA

Recent news which mentions NASDAQ:MIRA

MIRA Pharmaceuticals Advances Ketamir-2 Development Following Phase 1 Design Completion, Focusing On Early Clinical Efficacy Demonstration For Neuropathic Pain In 2025
Tickers MIRA
Tags NASDAQ:MIRA
From News Direct
MIRA Stock Earnings: Mira Pharmaceuticals Misses EPS for Q2 2024
Tickers MIRA
Tags NASDAQ:MIRA Earnings Reports Market News
From InvestorPlace
MIRA Pharmaceuticals (NASDAQ: MIRA) Reports Promising Pre-Clinical Trial Results For Mental Health Treatment, To Submit Investigational New Drug Application By End Of Year
Tickers MIRA
Tags NASDAQ:MIRA
From News Direct
MIRA Stock Earnings: Mira Pharmaceuticals Misses EPS for Q1 2024
Tickers MIRA
Tags Earnings Reports NASDAQ:MIRA MIRA
From InvestorPlace
MIRA Stock Earnings: Mira Pharmaceuticals Beats EPS for Q4 2023
Tickers MIRA
Tags Earnings Reports NASDAQ:MIRA MIRA
From InvestorPlace
MIRA Pharmaceuticals debuts on the Nasdaq with plans to revolutionize medicinal CBD and THC
Tags NASDAQ:MIRA
From News Direct
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.